WO2014059676A1 - Composition comprenant un amidon modifié d'ester oxydé - Google Patents

Composition comprenant un amidon modifié d'ester oxydé Download PDF

Info

Publication number
WO2014059676A1
WO2014059676A1 PCT/CN2012/083246 CN2012083246W WO2014059676A1 WO 2014059676 A1 WO2014059676 A1 WO 2014059676A1 CN 2012083246 W CN2012083246 W CN 2012083246W WO 2014059676 A1 WO2014059676 A1 WO 2014059676A1
Authority
WO
WIPO (PCT)
Prior art keywords
group
composition
modified starch
oxidized
formula
Prior art date
Application number
PCT/CN2012/083246
Other languages
English (en)
Inventor
Yuchao CHEN
Xinrong Lin
Baiwei CHEN
Jerome Senee
Jian Zhou
Original Assignee
L'oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by L'oreal filed Critical L'oreal
Priority to PCT/CN2012/083246 priority Critical patent/WO2014059676A1/fr
Priority to CN201280076501.7A priority patent/CN104717959B/zh
Publication of WO2014059676A1 publication Critical patent/WO2014059676A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/732—Starch; Amylose; Amylopectin; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations

Definitions

  • the present invention relates to compositions and, in particular, cleansing compositions comprising an oxidized ester modified starch, preferably an oxidized acetylated modified starch that are useful in cosmetic and personal care applications.
  • Formulations for personal care are conventionally known and have been used for a very long time.
  • Products such as shampoo, cleanser, and soap are well-established products belonging to this category.
  • such products are formulated so as to have an attractive smell, a sufficient foaming quality, and at least agreeable rinsing ability to the consumers.
  • Conventional cleansing compositions especially facial cleansing compositions typically contain surfactants, and polymers.
  • EP2042216 claims a body and hair cleansing product comprising water, substance from E list which comprises starch acetate under the code 1451 , and sodium stearoyl lactylate at the pH 4-8.
  • the present invention relates to a composition
  • a composition comprising at least one surfactant and an oxidized ester modified starch, preferably oxidized acetylated modified starch.
  • the present invention relates to a method for treating keratin material especially skin comprising applying to the keratinous material the composition according to the present invention.
  • the present invention relates to a use of an oxidized ester modified starch, preferably oxidized acetylated modified starch in producing a cleansing composition.
  • the composition according to the present application has advantages by virtue of improved foaming properties, rinsing abilities, and better skin finishing as compared with compositions in the prior art, and can be widely used as facial cleanser.
  • Figs.1 -6 are plots showing Performance of foam produced by different level of surfactant and Acetylated Oxidized Starch, wherein
  • Fig .1 illustrating the volume of the foam, rinseability level, and skin finish of the invention formulas 01 to 04.
  • FIG. 2 illustrating the volume of the foam, rinseability level, and skin finish of the invention formulas 05 to 08.
  • FIG. 3 illustrating the volume of the foam, rinseability level, and skin finish of the invention formulas 09 to 12.
  • Fig. 4 illustrating the volume of the foam, rinseability level, and skin finish of the invention formulas 13 to 16.
  • Fig. 5 illustrating the volume of the foam, rinseability level, and skin finish of the invention formulas 17 to 20.
  • Fig. 6 illustrating the volume of the foam, rinseability level, and skin finish of the invention formulas 21 to 24.
  • composition comprising at least one surfactant and an oxidized ester modified starch, preferably oxidized acetylated modified starch.
  • the composition optionally comprises one or more cosmetically acceptable adjuvants.
  • a composition comprising 1 -20% by weight of at least one surfactant and 1 - 10% by weight of an oxidized ester modified starch, preferably oxidized acetylated modified starch, based on the total weight of the composition.
  • the oxidized ester modified starch, preferably oxidized acetylated modified starch represents from about 1 % to about 10% of the total weight of the composition, more preferably from about 1 % to about 5% of the total weight of the composition, and most preferably from about 2.5% to about 3.5% of the total weight of the composition, including all ranges and subranges therebetween.
  • composition comprising 1 -20% by weight of at least one surfactant; 1 - 10% by weight of an oxidized ester modified starch, preferably oxidized acetylated modified starch; and optically one or more cosmetic acceptable adjuvants, based on the total weight of the composition.
  • a method for treating keratin material especially skin comprising applying to the keratinous material the composition.
  • the method for treating keratin material comprises cleansing the keratinous substrate.
  • oxidized ester modified starch preferably oxidized acetylated modified starch in producing a cleansing composition.
  • the expression “at least one” means one or more and thus includes individual components as well as mixtures/combinations.
  • oxidized means that at least one hydroxy group of the starch has been oxidized especially in position 6 of the glucose unit of the starch: the groups -CH 2 -OH for becoming an aldehyde group -C(O)-H or carboxy -C(O)-OH.
  • ester means that at least one hydroxy group of the glucose unit A of the starch is esterified by a (thio)carboxylic acid, especially (Ci-C8)(thio)carboxylic acid, and preferably an acetyl acid for obtaining an ester B, C or D with C and D corresponding respectively to the end or the beginning of the starch, Ra, Rb, Rc, Rd, and Re representing a hydrogen atom or a alkyl(thio)carbonyl group such as (Ci-C 8 )alkyl-C(O)- or (CrC 8 )alkyl-C(S)-, being understood that at least one of the radical chosen from Ra, Rb, Rc, Rd, and Re represents a alkyl(thio)carbonyl group in at least one unit of the starch :
  • oxidized ester means that at least one hydroxy group of the starch is “oxidized” as defined herein before, and at least on other hydroxy group of the starch is “esterified” as defined herein before.
  • the composition of the current invention comprises as a oxidized ester modified starch, a starch which contains at least a linear polymer of glucose i.e. an amylose derivative of formula (I) and/or at least a branched polymer of glucose i.e. an amylopectine derivative of formula (II), their anomers, preferably alpha (a) anomer, their cosmetically acceptable salts, and their solvates such as hydrates :
  • R 1 , R 2 , R 3 , R 4 , and R 5 identical or different, represent a hydroxymethyl group -CH 2 -OH or an oxidized form such as -CH 2 -C(O)-H, or -C(O)-OH, being understood that at least one of radical R 1 , R 2 , R 3 , R 4 , or R 5 represents an oxidized form, especially -C(O)-OH, and more preferably R 4 is in oxidized form and R 1 , R 2 , R 3 and R 5 represent a hydroxymethyl group ;
  • Csjalkylthiocarbonyloxy group preferably (Ci-C6)alkylcarbonyloxy group such as acetyl group
  • R 7 , R 8 , R 9 , R 10 , R 11 , R 13 , R 14 , R 15 , and R 16 represent hydroxy group and R 12 represents an (CrC 8 )alkylcarbonyloxy group, or an (Ci- Csjalkylthiocarbonyloxy group, preferably (Ci-C6)alkylcarbonyloxy group such as acetyl group
  • n an integer, especially comprized between 50 and 300 000
  • Average molecular masses of amylopectin modified molecules of formula (II) are at least 10 7 and may be as large as 10 9 .
  • the oxidized ester modified starch contains a mixture linear and branched polymer of glucose i.e. a mixture of amylose and amylopectine derivatives and more particularly in an amount between 10 and 40 % of amylose and between 60 and 90 % of amylopectine; more preferably between 15 and 20 % of amylose and between 80 and 85 % of amylopectine.
  • the oxidized ester modified starch contains a majority of amylose derivative, more specifically between 60 to 100%, such as between 80 to 85 %.
  • the oxidized ester modified starch preferably oxidized acetylated modified starch is constituted of amylose derivatives of formula (I) with an average molecular masses of amyloses from different commercial starches are in the 10 4 to 10 7 range , more particularly 10 5 — 10 6 range, which means that they have average degrees of polymerization (DP, number of glucosyl units per molecule) of is preferably comprised between 50 and 20000, especially between 100 and 10000 more particularly between 600 and 6000.
  • the oxidized ester modified starch, preferably oxidized acetylated modified starch of the current invention derives from any of the natural starch that is commonly found in the plants.
  • Such natural starch can be found, for example, in arrowroot, tapioca, potato, sweet potato, bean (fave, lentil, and pea), buckwheat, banana, barley, cassava, corn, kudzu, oca, rice, sago, sorghum, taro, wheat, yarns, and a mixture thereof.
  • tapioca, potato and wheat starch are used to produce the acetylated oxidized starch of the current invention.
  • the oxidized ester modified starch is a acetylated modified starch. More preferably "Acetylated modified starch" as used herein is a white powder widely used in food industry with INS Number of E 1451 , and with C.A.S. number 68187-08-6.
  • the viscosity of the oxidized ester modified starch, especially the acetylated modified starch is in the ranges from 10cP to 2000cP, preferably from 18cP to 1500cP, more preferably from 18cP to 1400cP under the temperature of at least 25 °C, preferably under the temperature of at least 45 °C, more preferably under the temperature of 85 °C.
  • the viscosity of the the oxidized ester modified starch especially the acetylated modified starch is tested using the equipment Brookfield Visco-Meter, NDJ-1 . the ester value of the said modified starch is above 0.05.
  • the content of the ester such as (CrC 8 )alkylcarbonyloxy group, or an (CrC 8 )alkylthiocarbonyloxy group, preferably (Ci-C6)alkylcarbonyloxy group such as acetyl group in particular acetyl group, of the oxidized ester modified starch, especially the acetylated modified starch is in the ranges between 0.1 % and 2.5%, preferably between 0.5% and 1 %. Being understood that the percentage correspond to the number of hydroxy group on starch have been esterified compared to the molecular weight of the modified starch.
  • the oxidized ester modified starch preferably oxidized acetylated modified starch of the current invention comprises, comparing to the total weight of the modified starch, from 0.3 % to 5% of the carboxyl group, preferably from 0.35% to 0.4% of the carboxyl group, more preferably from 0.37% to 0.4% of the carboxyl group.
  • the oxidized ester modified starch preferably oxidized acetylated modified starch of the current invention is an acetylated oxidized tapioca starch with a viscosity of 1400cP under the temperature of 25 °C. It contains 0.4% of carboxyl group, and having a content of acetyl group of 0.76%.
  • oxidized ester modified starch preferably oxidized acetylated modified starch contains at least one polymer of glucose of formula (I) and/or at least a branched polymer of glucose i.e. an amylopectine derivative of formula (II) as defined herein before wherein n is between 470 and 95 000 and
  • R 1 , R 2 , R 3 and R 5 represent a hydroxymethyl group
  • R 7 , R 8 , R 9 , R 10 , R 11 , R 13 , R 14 , R 15 , and R 16 represent a hydroxy group and;
  • R 4 represents a carboxy group -C(O)-OH or it salt
  • R 12 represents a (CrC6)alkylcarbonyloxy group such as acetyl group.
  • Such a starch also commercially available, for example, "Acetylated
  • Oxidized Starch from Zhucheng Xingmao Corn Developing Co., Ltd. , "OXC-10” from Suzhou Gaofeng Starch Technology Co., Ltd. and “MS#6100” from Asia Modified Starch Co., Ltd, etc.
  • Acetylated modified starch can be easily produced in a known manner in the art.
  • the manufacturing process includes two reaction steps oxidization and esterification.
  • Step 1 oxidization disperse the native starch into water and take place the oxidization by sodium hydroxide and sodium hypochlorite. Add sodium metabisulfite to stop the reaction then neutralize by hydrochloric acid.
  • Step 2 Esterification: esterify the oxidized starch obtained by step 1 by acetic anhydride and then neutralize by hydrochloric acid.
  • “Surfactant” of the current invention can be anionic surfactants, non- ionic surfactants, zwitterionic surfactants, or a mixture thereof, preferably anionic surfactants, zwitterionic surfactants, or a mixture thereof.
  • the at least surfactant is chosen from the anionic surfactant or "surface-active agent”.
  • Anionic surfactant is understood to mean an amphiphilic compound in which the hydrophobic part carries an anionic hydrophilic group with a cationic counterion which is generally metallic (alkali metal, such as Na or K) or ammonium; the hydrophilic group is thus polar and capable of dissociating to give anions in aqueous solution.
  • anionic part of the anionic surfactant is belonging to the group chosen from :
  • the anionic part comprising a cationic counter anion such as alkali or alkaline earth metal or organic cationic counter anion such as ammonium.
  • anionic surface-active agents of surface-active agents comprising carboxylate, sulfate, sulfonate, sulfoacetate, sulfosuccinate, phosphate, phosphonates, isethionate, sarcosinate, glutamate, lactylate or taurate anionic groups, salts of fatty acids, salts of galactosiduronic acids, salts of ether carboxylic acids and their mixtures, preferably sulfates, sulfonates, sulfosuccinates, phosphates, carboxylates, isethionates,, phosphonates, and a mixture.
  • anionic surface-active agent or agents according to the invention are chosen from:
  • anionic surface-active agents are advantageously found in the form of salts in the composition according to the invention, in particular of salts of alkali metals, such as sodium; of alkaline earth metals, such as, for example, magnesium; of ammonium salts; of amine salts; or of aminoalcohol salts.
  • the alkyl or acyl radicals of these various compounds preferably comprise from 12 to 20 carbon atoms.
  • the aryl radical denotes a phenyl or benzyl group.
  • the polyoxyalkylenated anionic surface- active agents preferably comprise from 2 to 50 alkylene oxide groups, in particular ethylene oxide groups.
  • the anionic surface-active agent is chosen from salts of fatty acids.
  • anionic surface-active agents are advantageously found in the form of salts in the composition according to the invention, in particular of salts of alkali metals, such as sodium; of alkaline earth metals, such as, for example, magnesium; of ammonium salts; of amine salts; or of aminoalcohol salts.
  • the alkyl or acyl radicals of these various compounds preferably comprise from 12 to 20 carbon atoms.
  • the aryl radical denotes a phenyl or benzyl group.
  • the polyoxyalkylenated anionic surface- active agents preferably comprise from 2 to 50 alkylene oxide groups, in particular ethylene oxide groups.
  • the anionic surface-active agent is chosen from salts of fatty acids.
  • Preferred anionic surfactants suitable for the current invention are chosen from salt of laureth sulfate, salt of lauryl sulfate, salt of laureth sulfosuccinate, and salt of cocoamphodiacetate, and a mixture thereof. More specifically, the anionic surfactants that can be used in the current invention can be found in the market. Non-limiting examples of such commercialized anionic surfactants are TEXAPON ® N 702 from COGNIS, TEXAPON ® LS 30 from COGNIS, TEXAPON ® SB 3 UNKONS from COGNIS, MIRANOL ® C2M CONC NP from RHODIA, and a mixture thereof. In some embodiments, the current invention comprises non-ionic surfactants.
  • nonionic surfactants according to the invention, mention may be made, alone or as mixtures, of fatty alcohols, a-diols and alkylphenols, these three types of compound being polyethoxylated, polypropoxylated and/or polyglycerolated and containing a fatty chain comprising, for example, 8 to 40 carbon atoms, the number of ethylene oxide or propylene oxide groups possibly ranging especially from 2 to 50 and the number of glycerol groups possibly ranging especially from 2 to 30.
  • polyethoxylated fatty amides preferably having from 2 to 30 mol of ethylene oxide, polyglycerolated fatty amides containing on average 1 to 5, and in
  • nonionic surfactant is chosen from:
  • fatty chain means a linear or branched, saturated or unsaturated hydrocarbon-based chain comprising from 6 to 30 carbon atoms and preferably from 8 to 30 carbon atoms.
  • alkyl polyglycosides or APGs these compounds are well known to a person skilled in the art (see, for example, Kirk-Othmer's Encyclopedia:
  • R 17 represents a linear or branched alkyl and/or alkenyl radical comprising approximately from 8 to 24 carbon atoms or an alkylphenyl radical, the linear or branched alkyl radical of which comprises from 8 to 24 carbon atoms;
  • R 18 represents an alkylene radical comprising approximately from 2 to 4 carbon atoms
  • G represents a sugar unit comprising from 5 to 6 carbon atoms
  • t denotes a value ranging from 0 to 10 and preferably from 0 to 4
  • v denotes a value ranging from 1 to 15.
  • Preferred alkyl polyglycosides according to the present invention are compounds of formula (I la) in which R 17 more particularly denotes a saturated or unsaturated and linear or branched alkyl radical comprising from 8 to 18 carbon atoms, t denotes a value ranging from 0 to 3 and more particularly still equal to 0, and G can denote glucose, fructose or galactose, preferably glucose.
  • the degree of polymerization i.e. the value of v in the formula (I la), can range from 1 to 15 and preferably from 1 to 4.
  • the average degree of polymerization is more particularly between 1 and 2 and even more preferentially from 1 .1 to 1 .5.
  • glycoside bonds between the sugar units are of 1 -6 or 1 -4 type and preferably of 1 -4 type.
  • Compounds of formula (I la) are represented in particular by the products sold by Cognis under the names Plantaren ® (600 CS/U, 1200 and 2000) or Plantacare ® (818, 1200 and 2000). Use may also be made of the products sold by Seppic under the names Triton CG 1 10 (or Oramix CG 1 10) and Triton CG 312 (or Oramix ® NS 10), the products sold by BASF under the name Lutensol GD 70 or the products sold by Chem Y under the name AG10 LK.
  • Use may also be made, for example, of C8-C16 alkyl 1 ,4- polyglucoside as a 53% aqueous solution, sold by Cognis under the reference Plantacare ® 818 UP, or PLANTACARE ® 2000 UP from COGNIS.
  • the mono- or polyglycerolated surfactants they preferably comprise on average from 1 to 30 glycerol groups, more particularly from 1 to 10 glycerol groups and in particular from 1 .5 to 5.
  • the monoglycerolated or polyglycerolated surfactants are preferably chosen from the compounds of the following formulae:
  • R' represents a saturated or unsaturated, linear or branched hydrocarbon- based radical comprising from 8 to 40 carbon atoms and preferably from 10 to 30 carbon atoms;
  • m is an integer between 1 and 30, preferably between 1 to 10 and more particularly from 1 .5 to 6; R may optionally comprise heteroatoms, for instance oxygen and nitrogen.
  • R' may optionally comprise one or more hydroxyl and/or ether and/or amide groups.
  • R' preferably denotes optionally mono- or polyhydroxylated C10-C20 alkyl and/or alkenyl radicals.
  • Use may be made, for example, of the polyglycerolated (3.5 mol) hydroxylauryl ether sold under the name Chimexane ® NF from Chimex.
  • the (poly)ethoxylated fatty alcohols that are suitable for performing the invention are chosen more particularly from alcohols containing from 8 to 30 carbon atoms, and preferably from 12 to 22 carbon atoms.
  • the (poly)ethoxylated fatty alcohols more particularly contain one or more linear or branched, saturated or unsaturated hydrocarbon-based groups, comprising 8 to 30 carbon atoms, which are optionally substituted, in particular with one or more (in particular 1 to 4) hydroxyl groups. If they are unsaturated, these compounds may comprise one to three conjugated or non-conjugated carbon-carbon double bonds.
  • the (poly)ethoxylated fatty alcohol(s) preferably have the following formula:
  • - Rf representing a linear or branched Cs-C 4 o alkyl or linear or branched Cs-C 4 o and preferably C 8 -C 3 o alkenyl group, optionally substituted with one or more hydroxyl groups, and
  • - n' is an integer between 1 and 200 inclusive, preferentially between 2 and 50 and more particularly between 8 and 30, such as 20.
  • the (poly)ethoxylated fatty alcohols are more particularly fatty alcohols comprising from 8 to 22 carbon atoms, oxyethylenated with 1 to 30 mol of ethylene oxide (1 to 30 OE).
  • fatty alcohols comprising from 8 to 22 carbon atoms, oxyethylenated with 1 to 30 mol of ethylene oxide (1 to 30 OE).
  • nonionic surfactants use is preferably made of C6-C2 4 alkyl polyglucosides and (poly)ethoxylated fatty alcohols, and C 8 -Ci 6 alkyl polyglucosides are more particularly used.
  • Non-limiting examples of the non-ionic surfactants that can be used in the current invention comprise fatty alcohol, alkyl glucoside, polyoxyalkylene glycol ether, sorbitan alkyl ester, ethanolamine and its derivatives, alkylamide oxide, block copolymer, polyethoxylated tallow amine, and a mixture thereof.
  • Preferred examples of the non-ionic surfactants as used in the current invention comprises coco- glucoside, decyl glucoside, cocamide MEA, dodecyldimethylamine oxide , and a mixture thereof.
  • Zwitterionic surfactant means a neutral surfactant having cationic and anionic charges in equilibrium; wherein the charges are generally on non adjacent atoms.
  • Amphoteric surfactant means also a surfactant having central equilibrated cationic and anionic charges which can be anionic in alkaline media, cationic in acid medium and non-ionic at neutral pH.
  • amphoteric or zwitterionic surfactant(s) that may be used in the present invention may especially be optionally quaternized secondary or tertiary aliphatic amine derivatives containing at least one anionic group, for instance a carboxylate, sulfonate, sulfate, phosphate or phosphonate group, and in which the aliphatic group or at least one of the aliphatic groups is a linear or branched chain comprising from 8 to 22 carbon atoms.
  • the zwitterionic or amphoteric surfactants can in particular be (non- restrictive list) derivatives of aliphatic secondary or tertiary amines, wherein the aliphatic radical is a linear or branched chain containing 8 to 22 atoms of carbon and containing at least one water-solubilising anionic group (for example carboxylate, sulphonate, sulphate, phosphate or phosphonate); the (C 8 -C 2 o) alkyl betaines, sulphobetaines, (C8-C20) alkyl amido(Ci -Ce) alkyl betaines or (C8-C20) alkyl amido(Ci-C6) alkyl sulphobetaines may also be cited.
  • amphoteric or zwitterionic surfactants examples include alkylbetaines, N-alkylamidobetaines and derivatives thereof, sultaines, alkylpolyaminocarboxylat.es (APAC) and alkyl amphoacetates, and mixtures thereof.
  • alkylbetaines examples include cocobetaine, for instance the product sold under the name Dehyton AB-30 ® by the company Cognis; laurylbetaine, for instance the product sold under the name Genagen KB ® by the company Clariant; oxyethylenated (10 EO) laurylbetaine, for instance the product sold under the name Lauryl Ether (10 OE) Betaine ® by the company Shin Nihon Portugal; oxyethylenated (10 EO) stearylbetaine, for instance the product sold under the name Stearyl Ether (10 OE) Betaine ® by the company Shin Nihon Portugal.
  • cocobetaine sold under the name Dehyton AB-30 ® by the company Cognis is used in the current invention.
  • N-alkylamidobetaines and derivatives thereof that may be mentioned, for example, are the cocamidopropylbetaine sold under the name Lebon 2000 HG ® by the company Sanyo, under the name Empigen BB ® by the company Albright & Wilson, or under the name DEHYTON® PK 45 by the company COGNIS; the lauramidopropylbetaine sold under the name Rewoteric AMB12P ® by the company Witco.
  • cocamidopropylbetaine sold under the name DEHYTON ® PK 45 from COGNIS is used in the current invention.
  • a sultaine that may be mentioned is the cocoyl- amidopropylhydroxysulfobetaine sold under the name Crosultaine C-50 ® by the company Croda.
  • Alkylpolyaminocarboxylat.es that may be mentioned include the sodium cocoylpolyaminocarboxylate sold under the name Ampholak 7 CX/C ® and Ampholak 7 CX ® by the company Akzo Nobel; the sodium stearylpolyamino- carboxylate sold under the name Ampholak 7 TX C ® by the company Akzo Nobel; the sodium carboxymethyloleylpolypropylamine sold under the name Ampholak XO7/C ® by the company Akzo Nobel.
  • APAC Alkylpolyaminocarboxylat.es
  • alkylamphoacetates examples include N- disodium N-cocoyl-N-carboxymethoxyethyl-N-carboxymethylethylenediamine (CTFA name: disodium cocamphodiacetate), for instance the product sold under the name Miranol C2M Concentrate NP ® by the company Rhodia Chimie; and N-sodium N- cocoyl-N-hydroxyethyl-N-carboxymethylethylenediamine (CTFA name: sodium cocamphoacetate).
  • amphoteric or zwitterionic surfactants that will be used more particularly are:
  • the at least one surfactant represents from 1 % to 20% of the total weight of the composition, more preferably from 5% to 16% of the total weight of the composition, and most preferably from 9% to 1 1 % of the total weight of the composition, including all ranges and subranges therebetween.
  • the composition of the invention may also contain adjuvants that are common in cosmetics and/or dermatology, such as active agents, preserving agents, antioxidants, complexing agents, pH modifiers (acidic or basic), fragrances, fillers, bactericides, odour absorbers, colorants (pigments and dyes), film-forming polymers, thickeners and/or gelling agents, and solvents like glycols ( glycerine, propylene glycol and butylenes glycol)
  • the amounts of these various adjuvants are those conventionally used in the field under consideration, for example from 0.1 % to 10% of the total weight of the composition.
  • these adjuvants may be introduced into the fatty phase, into the aqueous phase and/or into the lipid vesicles.
  • compositions of the present invention can comprise water.
  • cleansing compositions of the present invention comprise from 50% to 95% water, more preferably from 70% to 90% water, and more preferably from 80% to 86% water by weight with respect to the total weight of the composition, including all ranges and subranges there between.
  • Foaming property refers to volume of foam, being obtained at the end of rubbing hands, which is evaluated visually after collecting all of the foam in one hand; foam density, the compactness of foam quality, which is evaluated tactilely by pressing the foam between two palms at the end of rubbing hands. The more the foam is pressed, the less dense the foam is.
  • Rinseability refers to quickness of the strongest squeaky feeling of whole face occurs. Rinsing ability is evaluated tactilely during several rinsing movements, when fingers "rub" face from top to bottom of cheeks.
  • Skin finish refers to dry skin, astate of dehydration or relative deficiency of water, is evaluated visually by lifting cheeks by fingers, and observing conditions of dehydration lines on face; tight skin, tugging sensation, is evaluated by feeling absence or presence of tugging of skin when making facial expressions.
  • a cleansing composition was prepared containing the following ingredients:
  • Procedure for preparation of the cleansing composition disperse phase A in water, heat to 75 °C to dissolve the mixture, add phase B, C and D in order, cool down the temperature to 40 °C to add phase E and F, finish the procedure at 28 °C.
  • cleansing compositions were prepared containing the following ingredients in the same manner as that in example 1 :
  • COCO-BETAINE MIRATAINE® BB/FLA
  • COCO-BETAINE MIRATAINE® BB/FLA
  • COCO-BETAINE MIRATAINE® BB/FLA
  • acetylated modified starch improves the performance of foam in terms of the enhancement of foaming property, rinse ability and skin finish at level of 1 %, 5%, 10%, compared with the score from the products without the starch as such.
  • three categories of surfactant— anionic surfactants (SLS, DISODIUM LAURETH SULFOSUCCINATE), zwitterionic or amphoteric surfactants (coco betaine) and nonionic surfactants (APG) are used in different combination.
  • SLS anionic surfactants
  • zwitterionic or amphoteric surfactants coco betaine
  • APG nonionic surfactants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Detergent Compositions (AREA)

Abstract

L'invention concerne une composition de nettoyage, comprenant au moins un agent tensio-actif et un amidon oxydé acétylé, et un procédé de production de celle-ci. La composition de nettoyage selon la présente invention est utile dans des applications cosmétiques et de soins personnels.
PCT/CN2012/083246 2012-10-19 2012-10-19 Composition comprenant un amidon modifié d'ester oxydé WO2014059676A1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/CN2012/083246 WO2014059676A1 (fr) 2012-10-19 2012-10-19 Composition comprenant un amidon modifié d'ester oxydé
CN201280076501.7A CN104717959B (zh) 2012-10-19 2012-10-19 包含氧化酯改性的淀粉的组合物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2012/083246 WO2014059676A1 (fr) 2012-10-19 2012-10-19 Composition comprenant un amidon modifié d'ester oxydé

Publications (1)

Publication Number Publication Date
WO2014059676A1 true WO2014059676A1 (fr) 2014-04-24

Family

ID=50487489

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2012/083246 WO2014059676A1 (fr) 2012-10-19 2012-10-19 Composition comprenant un amidon modifié d'ester oxydé

Country Status (2)

Country Link
CN (1) CN104717959B (fr)
WO (1) WO2014059676A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3032116A1 (fr) * 2015-02-02 2016-08-05 Oreal Composition comprenant un amidon modifie et un silicate de magnesium
FR3124392A1 (fr) * 2021-06-24 2022-12-30 L'oreal composition nettoyante et/ou dÉmaquillante pour matiÈres kÉratineuses

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105831550A (zh) * 2016-04-12 2016-08-10 四川大学 一种新型食品抑菌剂及其制备方法
CN106925210A (zh) * 2017-04-14 2017-07-07 明光市外泰高分子材料有限公司 一种膨润土干燥剂及其制备方法
CN108250310A (zh) * 2017-12-28 2018-07-06 保龄宝生物股份有限公司 一种氧化乙酰化淀粉的制备方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060182702A1 (en) * 2005-02-11 2006-08-17 L'oreal Composition containing a cation, a cationic polymer, a solid compound and a starch, and cosmetic treatment process
KR100858544B1 (ko) * 2007-03-15 2008-09-12 주식회사 삼양제넥스 전분-비닐 공중합체의 제조방법
CN101411676A (zh) * 2007-06-29 2009-04-22 莱雅公司 包含四种表面活性剂、阳离子聚合物和有益试剂的洗涤剂化妆品组合物及其用途
FR2932382A1 (fr) * 2008-06-11 2009-12-18 Oreal Composition de lavage et de conditionnement des matieres keratiniques comprenant un polysaccharide oxyde particulier, utilisation et procede
US20110171153A1 (en) * 2009-12-23 2011-07-14 L'oreal Treatment of keratin fibres with volatile linear alkane(s), solid fatty alcohol(s) and polymeric thickener(s) containing sugar units

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2734713B1 (fr) * 1995-05-29 1997-07-04 Oreal Utilisation en cosmetique d'une composition solide expansee ayant une matrice constituee d'un reseau alveolaire forme a partir d'un produit naturel ou d'un derive apte a s'expanser
FR2881954B1 (fr) * 2005-02-11 2007-03-30 Oreal Composition cosmetique comprenant un cation, un polymere cationique, un compose solide et un amidon et procede de traitement cosmetique
CN101245157B (zh) * 2007-02-17 2011-06-15 长春大成特用玉米变性淀粉开发有限公司 成膜剂组合物和含有该组合物的淀粉质植物胶

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060182702A1 (en) * 2005-02-11 2006-08-17 L'oreal Composition containing a cation, a cationic polymer, a solid compound and a starch, and cosmetic treatment process
KR100858544B1 (ko) * 2007-03-15 2008-09-12 주식회사 삼양제넥스 전분-비닐 공중합체의 제조방법
CN101411676A (zh) * 2007-06-29 2009-04-22 莱雅公司 包含四种表面活性剂、阳离子聚合物和有益试剂的洗涤剂化妆品组合物及其用途
FR2932382A1 (fr) * 2008-06-11 2009-12-18 Oreal Composition de lavage et de conditionnement des matieres keratiniques comprenant un polysaccharide oxyde particulier, utilisation et procede
US20110171153A1 (en) * 2009-12-23 2011-07-14 L'oreal Treatment of keratin fibres with volatile linear alkane(s), solid fatty alcohol(s) and polymeric thickener(s) containing sugar units

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3032116A1 (fr) * 2015-02-02 2016-08-05 Oreal Composition comprenant un amidon modifie et un silicate de magnesium
WO2016124441A1 (fr) * 2015-02-02 2016-08-11 L'oreal Composition comprenant un amidon modifié et du silicate de magnésium
FR3124392A1 (fr) * 2021-06-24 2022-12-30 L'oreal composition nettoyante et/ou dÉmaquillante pour matiÈres kÉratineuses

Also Published As

Publication number Publication date
CN104717959B (zh) 2019-01-22
CN104717959A (zh) 2015-06-17

Similar Documents

Publication Publication Date Title
US10265261B2 (en) Cleansing compositions with conditioning properties
CN105722497B (zh) 包含至少一种甘氨酸盐型表面活性剂的发泡组合物
JP6666062B2 (ja) 起泡性クレンジング
EP2039751B1 (fr) Composition de nettoyage
US20020039976A1 (en) Cosmetic cleansing composition
US20110152150A1 (en) Cleansing composition
KR20150056785A (ko) 피부 또는 모발용 세정 조성물
JP5041894B2 (ja) 洗浄剤組成物
KR20180108833A (ko) 개인 위생 조성물 및 이러한 조성물의 사용 방법
KR20190097180A (ko) 세정 조성물
WO2014059676A1 (fr) Composition comprenant un amidon modifié d'ester oxydé
EP3229767B1 (fr) Composition de nettoyage de la peau comprenant un polyethylene glycol et un polyether ester
WO1995008615A1 (fr) Composition detergente
CN111542307B (zh) 用于护理角蛋白材料的组合物、其方法和用途
JP5762731B2 (ja) 皮膚洗浄剤組成物
JP4181153B2 (ja) 発泡性クレンジング組成物
JP7126945B2 (ja) パーソナルケア組成物及び該組成物の使用方法
JP5093876B2 (ja) 洗浄剤組成物
KR20210032799A (ko) 화장료 조성물 및 이를 이용한 세정제
JP4101827B2 (ja) 起泡性クレンジング組成物
WO2023200753A1 (fr) Composition de soins personnels contenant un biotensioactif
JP2019056127A (ja) アスパラギン酸のタウリン誘導体を含有する界面活性剤組成物及び当該界面活性剤組成物を含有する洗浄剤組成物
CN116234533A (zh) 清洁角蛋白物质的组合物和方法
JP2023048243A (ja) ポリアルキレンイミン誘導体を含む化粧料。
JP2013064070A (ja) 洗浄剤組成物

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12886519

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12886519

Country of ref document: EP

Kind code of ref document: A1